The Report Guru

In Vitro Diagnostics (IVD) Quality Control Market : he global IVD quality controls market is poised to reach USD 1.04 Billion by 2022, at a CAGR of 3.5% from 2017 to 2022. The report  " In Vitro Diagnostics (IVD) Quality Control Market  Application (Immunoassay, Molecular Diagnostics, Microbiology, Hemostasis, Hematology) Source (Serum, Whole Blood, Urine) Type (Instrument Specific, Third Party Control) - Global Forecast to 2022" , The global IVD quality controls market is poised to reach USD 1.04 Billion by 2022, at a CAGR of 3.5% from 2017 to 2022. Browse 162 Market Data Tables and 36 Figures spread through 219 Pages and in-depth TOC on  "In Vitro Diagnostics (IVD) Quality Control Market Application (Immunoassay, Molecular Diagnostics, Microbiology, Hemostasis, Hematology) Source (Serum, Whole Blood, Urine) Type (Instrument Specific, Third Party Control) - Global Forecast to 2022" https://www.marketsandmarkets.com/Market-Reports/in-vitro-diagnostics-quality-

According to the new market research report " Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022" , published by MarketsandMarkets™, the market is projected to reach USD 10.88 Billion by 2022 from USD 9.32 Billion in 2017, growing at a CAGR of 3.1%. Don’t miss out on business opportunities in Defibrillators Market . Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=549 Factors such as technological advancements in defibrillators, rising prevalence of target diseases, growing focus on providing public access defibrillation, and rising number of training & awareness programs across the globe are driving the growth of this market. By product, the implantable car

Global  structural heart devices market  is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%. Players in this market compete with each other to deliver superior and advanced technologies for heart valve repair and replacement. In 2017, the structural heart devices market was dominated by a few large players, namely, Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK). Product launches & approvals; acquisitions; expansions; and partnerships & agreements were the key strategies adopted by key players between 2015 and 2018. Some of the key players that adopted these strategies are Edwards Lifesciences (US), Medtronic (Ireland), Boston Scientific (US), Abbott (US), LivaNova (UK), Micro Interventional Devices (US), Braile Biomédica (Brazil), and CryoLife (US). To know the Insights download the  pdf brochure Edwards Lifesciences held the leading posit

According to a new market research report  " eHealth Market   by Product (EHR, PACS & VNA, RIS, LIS, CVIS, Telehealth, eRx, HIE, Patient Portal, Medical Apps), Services (Remote Patient Monitoring, Diagnostic Services) End User (Hospitals, Home Healthcare, Payers, Pharmacy) - Global Forecast to 2023 " , published by MarketsandMarkets™, the market is expected to reach  USD 132.35 Billion  by 2023 from  USD 47.60 Billion  in 2018, at a CAGR of 22.7%. Early buyers will receive 1 0% customization on this report Factors driving market growth include the regulatory mandates and government initiatives for the implementation of eHealth solutions; growing mHealth, telehealth, and remote patient monitoring markets; and increasing need to curtail the escalating healthcare costs. In addition, the emerging market in  China ,  India , and  Australia ; rising shift towards patient-centric healthcare delivery; and growing use of eHealth solutions in outpatient care facilities are fu

The HIV Diagnosis Market is consolidated in nature due to the presence of a few large players. The prominent players in the market include Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.). Siemens AG (Germany) was the largest player in the global HIV Diagnosis Market 2015. The company‘s laboratory diagnostics segment includes clinical chemistry, drug testing diagnostics, hematology, hemostasis, immunoassay, infectious disease testing, integrated chemistry, plasma proteins, and urinalysis products. Of these segments, immunoassay and infectious disease testing segment deal with the market. The company focuses on both organic and inorganic growth strategies to enhance its footprint in the market. The company introduced a number of advanced HIV diagnosis

The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017, at a CAGR of 18.3% during the forecast period. Factors such as technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, growing preference for wireless connectivity among healthcare providers, and increasing awareness about physical fitness are driving the growth of this market. The report segments the global wearable medical devices market into type, application, device type, distribution channel, and region. Based on type , the wearable medical devices market is segmented into activity monitors, smartwatches, smart clothing, and patches. In 2017, the activity monitors segment is expected to account for the largest share of the wearable medical devices market.  Based on application , the wearable medical devices market is segmented into sports an

The global  clinical microbiology market  is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period. The technological advancements in the disease diagnostics, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments in the field of disease diagnosis are the key factors driving the growth of the clinical microbiology market during the forecast period. Strategic analysis of the market developments between 2014 and 2018 revealed that growth strategies such as product launches and enhancements; acquisitions; agreements, partnerships, collaboration; and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the clinical microbiology market. Among these business strategies, product launches & enhancements and partnerships & collaborations were the two most widely adopted grow

The global Perfusion Systems Market is expected to reach USD 1,198.8 Million by 2021 from USD 989.4 Million in 2016, at a CAGR of 3.9%. The growth of the market can be attributed to the increasing prevalence of cardiovascular & respiratory diseases, initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market. The Perfusion Systems Market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region. Geographically, North America is estimated to account for the largest share of the global market, followed by Europe. The Asia-Pacific region is expected to witness the highest growth in the market during the forecast period. This growth will be particularly centered on Chin

This report studies the global ECMO machine market for the forecast period of 2016 to 2021. This market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. A number of factors such as the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to heart & lung transplantation, growing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements are the significant factors driving the growth of this market. In addition, the growing aging population and the number of people suffering from cardiopulmonary diseases in populous countries such as India and China are factors that are expected to offer significant growth opportunities for ECMO systems. The global market is segmented on the basis of modality, applications, and regions. Based on the modality, the global market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The ve

The global oral care/oral hygiene market is projected to reach USD 53.97 billion by 2022 from USD 43.31 billion in 2017, at a CAGR of 4.5%. The market is consolidated in nature with the presence of many local, regional, and global players. Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), and Unilever plc (U.K.) were the major players in this market. The companies are mainly focusing on product launches, agreements, and expansions to strengthen their product offerings and establish a strong geographical foothold. Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=80546246 Colgate-Palmolive Company (U.S.) dominated the global oral care market in 2016. The company significantly focuses on product innovation, product enhancement, and product launches; it invested USD 289 million for R&D activities in 2016. The company launched two new products, Colgate Optic White Toothbrush + Whitening Pen (the toothbrush with

Product Development and Commercialization are the Key Strategies Adopted by Market Players to Foster their Growth in the Global Thrombectomy Devices Market https://www.marketsandmarkets.com/Market-Reports/thrombectomy-devices-market-222966801.html The global thrombectomy devices market is estimated to reach USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during the forecast period. The growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are some key factors propelling the growth of this thrombectomy devices market. The key players focused on various strategies such as product launches and enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase their shares in the global thrombectomy devices market. Product launches & enhancements is the strategy adopted

Market growth factors Factors such as the growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, technological advancements in the field of PCR, and increasing investments and availability of funds for PCR-based research are driving the growth of the global dPCR and qPCR market. What experts says about the growth of this market? According to latest research Digital PCR and qPCR Market is expected to reach USD 5.31 Billion by 2022, growing at a CAGR of 8.9% during the forecast period.  The report dPCR and qPCR market during the forecast period of 2017 to 2022. Get Report Sample Copy: https://www.marketsandmarkets.com/requestsample.asp?id=174151204 (Source: MarketsandMarkets™) Key players The key players in the digital PCR and real-time PCR (qPCR) market focused on various strategies such as product launches and approvals; partnerships, collaborations and agreements; mergers and acquisitions; and expansions to enhance their